Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT02231164
Title LUME-Columbus: Nintedanib Plus Docetaxel in Advanced Non-small Cell Lung Cancer With Translational Research
Recruitment Terminated
Gender both
Phase Phase III
Variant Requirements Yes
Sponsors Boehringer Ingelheim
Indications

lung adenocarcinoma

Therapies

Docetaxel

Nintedanib

Age Groups: adult
Covered Countries USA

Facility Status City State Zip Country Details
Boehringer Ingelheim Investigational Site Chandler Arizona United States Details
Boehringer Ingelheim Investigational Site Fayetteville Arkansas United States Details
Boehringer Ingelheim Investigational Site Highland California United States Details
Boehringer Ingelheim Investigational Site Rancho Mirage California United States Details
Boehringer Ingelheim Investigational Site Paducah Kentucky United States Details
Boehringer Ingelheim Investigational Site Farmington New Mexico United States Details
Boehringer Ingelheim Investigational Site Minot North Dakota United States Details
Boehringer Ingelheim Investigational Site Blacksburg Virginia United States Details
Boehringer Ingelheim Investigational Site Kennewick Washington United States Details
Boehringer Ingelheim Investigational Site Batumi Georgia Details
Boehringer Ingelheim Investigational Site Tbilisi Georgia Details
Boehringer Ingelheim Investigational Site Bangkok Thailand Details
*Shaded cells indicate that there was no data available from clincialtrials.gov for the field